Acute and sub-chronic toxicity study of novel polyherbal formulation in non-alcoholic fatty liver using Wistar rats

References

• Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1), 73–84 (2016).
   PubMed Web of Science ®Google Scholar
• Younossi Z, Anstee QM, Marietti M et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature reviews Gastroenterology & hepatology. 15(1), 11–20 (2018).
   PubMed Web of Science ®Google Scholar
• Angulo P, Kleiner DE, Dam-Larsen S et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149(2), 389–397.e310 (2015).
   PubMed Web of Science ®Google Scholar
• Fan J-G, Kim S-U, Wong VW-S. New trends on obesity and NAFLD in Asia. J. Hepatol. 67(4), 862–873 (2017).
   PubMed Web of Science ®Google Scholar
• Lambert JE, Ramos–Roman MA, Browning JD, Parks EJ. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146(3), 726–735 (2014).
   PubMed Web of Science ®Google Scholar
• Alexander M, Loomis AK, Fairburn-Beech J et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC medicine. 16, 1–11 (2018).
   Web of Science ®Google Scholar
• Padda J, Khalid K, Khedr A et al. Non-alcoholic fatty liver disease and its association with diabetes mellitus. Cureus 13(8), (2021).
   Web of Science ®Google Scholar
• Bandaranayake WM. Quality control, screening, toxicity, and regulation of herbal drugs. Modern phytomedicine: turning medicinal plants into drugs. 25–57 (2006).
   Google Scholar
• Glass OK, Radia A, Kraus WE, Abdelmalek MF. Exercise training as treatment of nonalcoholic fatty liver disease. Journal of Functional Morphology and Kinesiology. 2(4), 35 (2017).
   Google Scholar
• Chowdhury AB, Mehta KJ. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clinical and experimental medicine. 1–13 (2022).
   Web of Science ®Google Scholar
• Lin G, Xinhe Z, Haoyu T et al. Epidemiology and lifestyle survey of non-alcoholic fatty liver disease in school-age children and adolescents in Shenyang, Liaoning. BMC pediatrics. 22(1), 1–9 (2022).
   PubMed Web of Science ®Google Scholar
• Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology 158(7), 1851–1864 (2020).
   PubMed Web of Science ®Google Scholar
• Beger RD, Dunn W, Schmidt MA et al. Metabolomics enables precision medicine:“a white paper, community perspective”. Metabolomics. 12, 1–15 (2016).
   Web of Science ®Google Scholar
• Kumar A, Rajendran V, Sethumadhavan R, Purohit R. In silico prediction of a disease-associated STIL mutant and its affect on the recruitment of centromere protein J (CENPJ). FEBS Open Bio. 2, 285–293 (2012).
   PubMed Web of Science ®Google Scholar
• Zwickl CM, Graham J, Jolly R et al. Principles and Procedures for Assessment of Acute Toxicity Incorporating In Silico Methods. Computational toxicology (Amsterdam, Netherlands). 24, (2022).
   PubMedGoogle Scholar
• Bhardwaj V, Purohit R. Computational investigation on effect of mutations in PCNA resulting in structural perturbations and inhibition of mismatch repair pathway. Journal of biomolecular structure & dynamics. 38(7), 1963–1974 (2020).
   PubMed Web of Science ®Google Scholar
• Tanwar G, Mazumder AG, Bhardwaj V et al. Target identification, screening and in vivo evaluation of pyrrolone-fused benzosuberene compounds against human epilepsy using Zebrafish model of pentylenetetrazol-induced seizures. Sci Rep. 9(1), 7904 (2019).
   PubMedGoogle Scholar
• Raies AB, Bajic VB. In silico toxicology: computational methods for the prediction of chemical toxicity. Wiley Interdisciplinary Reviews: Computational Molecular Science. 6(2), 147–172 (2016).
   PubMed Web of Science ®Google Scholar
• Koul I, Kapil A. Effect of diterpenes from Andrographis paniculata on antioxidant defense system and lipid peroxidation. Indian Journal of Pharmacology. 26(4), 296 (1994).
   Google Scholar
• Kapil A, Koul I, Banerjee S, Gupta B. Antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata. Biochem. Pharmacol. 46(1), 182–185 (1993).
   PubMed Web of Science ®Google Scholar
• Hussain F, Rana Z, Shafique H, Malik A, Hussain Z. Phytopharmacological potential of different species of Morus alba and their bioactive phytochemicals: a review. Asian Pacific journal of tropical biomedicine. 7(10), 950–956 (2017).
   Web of Science ®Google Scholar
• Loha M, Mulu A, Abay SM, Ergete W, Geleta B. Acute and subacute toxicity of methanol extract of Syzygium guineense leaves on the histology of the liver and kidney and biochemical compositions of blood in rats. Evidence-Based Complementary and Alternative Medicine. 2019, (2019).
   PubMed Web of Science ®Google Scholar
• Jonsson M, Jestoi M, Nathanail AV et al. Application of OECD Guideline 423 in assessing the acute oral toxicity of moniliformin. Food and chemical toxicology. 53, 27–32 (2013).
   PubMed Web of Science ®Google Scholar
• DRUGS AND COSMETICS RULES 1988, Ministry of Health and Family Welfare (Department of Health). Eight Amendment (1988).
   Google Scholar
• Stevens MT. The value of relative organ weights. Toxicology 5(3), 311–318 (1976).
   PubMed Web of Science ®Google Scholar
• Committee ES. Guidance on conducting repeated-dose 90-day oral toxicity study in rodents on whole food/feed. EFSA Journal. 9(12), 2438 (2011).
   Google Scholar
• Sathyapriya A, Suresh S, Mohanapriya B, Kanagaraj C, Kumar MS. Biosynthesis Of Silver Nanoparticles From The Leaf Extracts Of Euphorbia Hirta And Evaluation Of Their Antidiabetic Activity.
   Google Scholar
• Axelrod B, Cheesbrough TM, Laakso S. [53] Lipoxygenase from soybeans: EC 1.13. 11.12 Linoleate: oxygen oxidoreductase. In: Methods in Enzymology. Elsevier, 441–451 (1981).
   Google Scholar
• Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24(7), 908–922 (2018).
   PubMed Web of Science ®Google Scholar
• Mantovani A, Dalbeni A. Treatments for NAFLD: State of Art. International Journal of Molecular Sciences. 22(5), 2350 (2021).
   PubMed Web of Science ®Google Scholar
• Enmozhi SK, Raja K, Sebastine I, Joseph J. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. Journal of Biomolecular Structure and Dynamics. 39(9), 3092–3098 (2021).
   PubMed Web of Science ®Google Scholar
• Anuragh S, Ilango K. Role of medicinal plants and their chemical constituents in ameliorating the cause for non-alcoholic fatty liver disorder—A review. Journal of Applied Pharmaceutical Science. 12(6), 043–055 (2022).
   Google Scholar
• Kaewdech A, Nawalerspanya S, Assawasuwannakit S, Chamroonkul N, Jandee S, Sripongpun P. The use of Andrographis paniculata and its effects on liver biochemistry of patients with gastrointestinal problems in Thailand during the COVID-19 pandemic: a cross sectional study. Scientific Reports. 12(1), 18213 (2022).
   PubMed Web of Science ®Google Scholar
• Armanini D, De Palo C, Mattarello M et al. Effect of licorice on the reduction of body fat mass in healthy subjects. J. Endocrinol. Invest. 26, 646–650 (2003).
   PubMed Web of Science ®Google Scholar
• Badwaik HR, Kumari L, Nakhate K, Verma VS, Sakure K. Phytoconstituent plumbagin: chemical, biotechnological and pharmaceutical aspects. Studies in natural products chemistry. 63, 415–460 (2019).
   Google Scholar
• Nazari S, Rameshrad M, Hosseinzadeh H. Toxicological effects of Glycyrrhiza glabra (licorice): a review. Phytotherapy research. 31(11), 1635–1650 (2017).
   PubMed Web of Science ®Google Scholar